Brief: BRAIN Biotech Extends Its Genome-Editing Toolbox With Addition Of BRAIN-Metagenome-Cas 01 Nuclease
Dec 8 (Reuters) - BRAIN BIOTECH AG BNNn.DE :
* IS EXTENDING ITS PROPRIETARY GENOME-EDITING TOOLBOX WITH
ADDITION OF BRAIN-METAGENOME-CAS 01 (BMC01) NUCLEASE
* THIS ADDITIONAL NUCLEASE WILL EXTEND BRAIN'S PROPRIETARY
GENOME
EDITING COMPETENCE AND FURTHER ENHANCE OVERALL ECONOMIC
POTENTIAL OF PLATFORM, IN CASE PATENT PROTECTION IS GRANTED
Source text for Eikon: ID:nEQc9trsHa
Further company coverage: BNNn.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on BRAIN Biotech AG
See all newsBrief: BRAIN Biotech 9M EBITDA EUR -1.6 Million
CEOs Lukas Linnig And Michael Krohn To Leave Co
Brief: Brain Biotech Signs Exclusive Pharma Licensing Agreement With Akribion For Up To EUR 92.3 Million Milestone Fees Plus Royalties
Brief: BRAIN Biotech 9M Adj. EBITDA at EUR -1.2 Million
Europe Research Roundup: AB Foods, Bunzl, Barratt